These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The problem of underdosing of angiotensin-converting enzyme inhibitors is markedly overrated: results from a study of patients discharged from hospital after an acute myocardial infarction. Kvan E; Reikvam A; Eur J Clin Pharmacol; 2004 May; 60(3):205-10. PubMed ID: 15034703 [TBL] [Abstract][Full Text] [Related]
7. [ACE inhibitor after myocardial infarct: are there differences?]. Jahrmärker H Herz; 1995 Aug; 20(4):293-6. PubMed ID: 7557832 [No Abstract] [Full Text] [Related]
8. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction. Beckwith C; Munger MA Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800 [TBL] [Abstract][Full Text] [Related]
10. ACE inhibitors after myocardial infarction. Hall AS; Cooke GA; Tan LB Lancet; 1994 Jun; 343(8913):1632-3; author reply 1633-4. PubMed ID: 7911933 [No Abstract] [Full Text] [Related]
11. [GISSI-3 and ISIS-4: administration of ACE inhibitors soon after myocardial infarct]. Heinzl S Med Monatsschr Pharm; 1994 Jan; 17(1):1. PubMed ID: 8127246 [No Abstract] [Full Text] [Related]
12. Acute myocardial infarction in diabetes mellitus: lessons learned from ACE inhibition. Nesto RW; Zarich S Circulation; 1998 Jan 6-13; 97(1):12-5. PubMed ID: 9443424 [No Abstract] [Full Text] [Related]
13. Angiotensin-converting enzyme inhibition in myocardial infarction--Part 2: Clinical issues and controversies. Huckell VF; Bernstein V; Crowell R; Dagenais GR; Higginson LA; Isserow S; Laramée P; Liu P; McCans JL; Orchard RC; Prewitt R; Quinn BP; Samson M; Turazza F; Warnica JW; Wielgosz A Can J Cardiol; 1997 Feb; 13(2):173-82. PubMed ID: 9070169 [TBL] [Abstract][Full Text] [Related]
14. Myocardial infarction: when and how should we initiate treatment with ACE inhibitors? GISSI-3 Investigators. Latini R; Maggioni AP; Zuanetti G Cardiology; 1996; 87 Suppl 1():16-22. PubMed ID: 8681316 [TBL] [Abstract][Full Text] [Related]
16. Lisinopril. A review of its pharmacology and clinical efficacy in the early management of acute myocardial infarction. Goa KL; Balfour JA; Zuanetti G Drugs; 1996 Oct; 52(4):564-88. PubMed ID: 8891468 [TBL] [Abstract][Full Text] [Related]
18. The use of angiotensin converting enzyme inhibitors in asymptomatic patients with left ventricular dysfunction after myocardial infarction. Bazunga M Conn Med; 1995 Nov; 59(11):663-6. PubMed ID: 8565511 [No Abstract] [Full Text] [Related]
19. ACE inhibitors after myocardial infarction: patient selection or treatment for all? Lindsay HS; Zaman AG; Cowan JC Br Heart J; 1995 May; 73(5):397-400. PubMed ID: 7786645 [No Abstract] [Full Text] [Related]